Trials / Sponsors / Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc.
Industry · 8 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Safety Study of XT-150 in Participants With ALS Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | 2025-11-01 |
| Completed | Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain Facet Joint Pain, Back Pain, Inflammation | Phase 2 | 2022-02-24 |
| Withdrawn | Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis Osteoarthritis, Spine | Phase 1 / Phase 2 | 2021-10-01 |
| Terminated | Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain Neuropathic Pain | Phase 1 | 2021-04-14 |
| Completed | Efficacy and Safety of XT-150 in Osteoarthritis of the Knee Osteoarthritis, Knee | Phase 2 | 2020-02-14 |
| Completed | Follow on Extension of XT-150-1-0201 Osteoarthritis, Knee | Phase 1 | 2019-03-20 |
| Completed | Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain Osteoarthritis, Knee | Phase 1 | 2018-06-08 |
| Completed | Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pai Osteoarthritis, Knee | Phase 1 | 2018-03-21 |